
Status:
Varies by program. ANZ program is closed. Research challenges may be open
Provider:
Merck Group
Amount:
$5,000+ to AUD 136,000 plus in-kind support depending on program
Rounds:
Programs are offered on a regular basis, not on a set annual schedule
Location:
National
Who Can Apply:
Biotech and biopharmaceutical start-ups, entrepreneurs, scientists, and students
Co-contribution Required?
No
Closing Date:
Varies by program. You must check the official Merck website for current dates
Purpose and Program Overview
Merck offers several grant programs. They aim to help biopharmaceutical and biotech start-ups, scientists, and students. The intent is to help these groups advance their innovative ideas. The grants provide resources and expertise. This helps accelerate the path to commercialisation.
These programs recognise emerging companies with strong potential. They also support research in key areas of future importance. Merck’s broader role is to foster innovation within the life science industry. They provide tangible support. This helps new companies overcome challenges in drug development and manufacturing.
The grant recipients get products, services, and consultation. This support is designed to help them develop therapeutic solutions for patients. These solutions address critical health issues. These include cancer, brain tumours, and cardiovascular disorders.
Key Grant Details of Merck Grant Programs
- Grant amount or funding range: Varies by program. The ANZ grant grand prize is valued at AUD 136,000 in products and services. Other prizes of up to AUD 19,800 are also available. The research grants offer up to EUR 500,000 per year for up to three years.
- Application open and close dates: There are no set annual dates. The programs are offered on a regular basis in different regions. Applicants must check the Merck website for current opportunities and deadlines.
- Eligible industries or business types: Biopharmaceutical and biotech start-ups, entrepreneurs, scientists, and students.
- Required co-contributions: Not required. The grant provides in-kind products and services.
- Location/state/territory applicability: The ANZ Grant Program is specific to Australia and New Zealand. The Research Challenges are global but often have specific eligibility requirements.
Priority Sectors
Merck Grant Programs target several key sectors. These are therapeutic solutions for:
- Oncology (cancer)
- Brain tumours
- Osteoarthritis
- Cardiovascular disorders
- Infectious diseases
Specific challenges may also be announced for the annual research grants.
Funding Scope
- Minimum and maximum amounts per stream: The ANZ program offers a grand prize and finalist prizes. The grand prize is valued at AUD 136,000. Finalist prizes are valued at AUD 19,800. The research grants offer varying amounts. Some have been up to EUR 500,000 per year.
- Categories or streams of funding: Funding is in the form of in-kind support. It includes products, services, and consultation. These grants are for project development and commercialisation.
- Project timeline or eligible funding duration: Not specified. It depends on the project scope and the grant provided.
Grant Amount in Total
The total funding pool for all of Merck’s grant programs is not stated. The Advance Biotech Grant Program has awarded technologies and consultation to over 40 companies since 2014. The 2024 ANZ program had a total grant pool of AUD 175,600.
Eligibility Criteria
- Business structure or size: The programs target emerging start-up biopharmaceutical and biotech companies.
- Registered business location: For the ANZ program, the business must be located in Australia or New Zealand.
- Minimum/maximum turnover: Not specified. The grants are for early-stage companies.
- ABN/GST status: Not specified.
Eligible Activities and Expenses
Merck Grant Programs provide in-kind products and services. These support activities such as:
- Research and development.
- Biopharmaceutical production and manufacturing.
- Upstream, downstream, and formulation consultation.
- Drug development.
Assessment Process
The grants are competitive. Applications are judged on several criteria. These include:
- The scientific and societal merit of the therapy.
- The clinical strategy and stage of the project.
- Process challenges and expertise gaps.
- How Merck’s resources can help the project.
Recent Program Updates
The 2024 ANZ Advance Biotech Grant Program recently opened for applications. Merck also expanded its Emerging Biotech grant program to Australia and New Zealand in 2024. The program is offered in various regions globally.
Application Tips
- Describe your therapeutic focus and clinical strategy in detail.
- Explain how Merck’s products, services, and expertise can help you.
- Be clear about the specific challenges your project faces.
- Demonstrate the innovation and potential impact of your work.
- Align your proposal with Merck’s focus on accelerating commercialisation.
Where to Get Help
Consider consulting with a professional grant specialist like Pattens Group. We offer initial assessments to review your business’s eligibility and evaluate how well your project aligns with the grant’s objectives. You can also visit the Merck Group website for application templates and further guidance.
Interested in Merck Grant Programs?
Request a call back
Disclaimer: This grants search engine exclusively searches for business grants and does not include community grants or grants for nonprofit organisations.
